Tüüp : |
Ajaleht |
|
Uurimisrühmad : |
Vancouver - Children\'s and Women\'s Health Center of British Columbia |
Autor : |
Ensom MHH, Decarie D, Sheppard I. |
Pealkiri : |
Stability of lansoprazole in extemporaneously compounded suspensions for nasogastric or oral administration. |
Publikatsioon : |
Can J Hosp Pharm ; 60, 3: 184-191. 2007 |
|
Tõendite tase : |
|
Füüsikaline stabiilsus : |
|
Keemiline püsivus : |
|
Muud meetodid : |
|
Kommentaarid : |
|
Ingredientide nimekiri
Lansoprazole
|
![Prootonpumba inhibiitor Prootonpumba inhibiitor](./images/Picto.504.jpg) |
![Stabiilsus lahustes Stabiilsus lahustes](./images/Picto.591.jpg) |
![Klaas Klaas](./images/Picto.532.jpg) |
![Kapslid Kapslid](./images/Picto.10387.png) |
150 mg ®=? (Abbott Laboratories) |
|
25°C |
![Valgus Valgus](./images/Picto.528.gif) |
91 |
![Päev Päev](./images/Picto.542.gif) |
|
|
![Stabiilsus lahustes Stabiilsus lahustes](./images/Picto.591.jpg) |
![Klaas Klaas](./images/Picto.532.jpg) |
![Kapslid Kapslid](./images/Picto.10387.png) |
150 mg ®=? (Abbott Laboratories) |
NaHCO3 8.4% |
25 ml |
NaOH |
1N = 1.7 ml |
OraPlus® / OraSweet® (1:1) |
23.3 ml |
PH= |
8.4 |
|
25°C |
![Valgus Valgus](./images/Picto.528.gif) |
91 |
![Päev Päev](./images/Picto.542.gif) |
|
|
![Stabiilsus lahustes Stabiilsus lahustes](./images/Picto.591.jpg) |
![Klaas Klaas](./images/Picto.532.jpg) |
![Kapslid Kapslid](./images/Picto.10387.png) |
150 mg ®=? (Abbott Laboratories) |
|
4°C |
![Kaitsta valguse eest Kaitsta valguse eest](./images/Picto.526.jpg) |
91 |
![Päev Päev](./images/Picto.542.gif) |
|
|
![Stabiilsus lahustes Stabiilsus lahustes](./images/Picto.591.jpg) |
![Klaas Klaas](./images/Picto.532.jpg) |
![Kapslid Kapslid](./images/Picto.10387.png) |
150 mg ®=? (Abbott Laboratories) |
NaHCO3 8.4% |
25 ml |
NaOH |
1N = 1.7 ml |
OraPlus® / OraSweet® (1:1) |
23.3 ml |
PH= |
8.4 |
|
4°C |
![Kaitsta valguse eest Kaitsta valguse eest](./images/Picto.526.jpg) |
91 |
![Päev Päev](./images/Picto.542.gif) |
|
|
|
|